Esketamine, a drug that blocks NMDA receptors, improved neurological function and promoted nerve repair in mice with intracerebral hemorrhage. RNA sequencing and network pharmacology identified neurotrophin-3 and the PI3K/AKT signaling pathway as key targets. Experiments confirmed that esketamine increased NTF3 protein levels, and blocking the PI3K/AKT pathway with a specific inhibitor reduced the drug's therapeutic effects. The findings suggest esketamine activates the NTF3/PI3K/AKT pathway to aid recovery after brain hemorrhage.
An integrated mindfulness-based programme combining the Community Resiliency Model and mindfulness-based stress reduction reduced posttraumatic stress disorder symptoms and improved antiretroviral therapy adherence in people with HIV. Eighty-two participants with HIV and PTSD were assigned to either the intervention or a control group. The intervention group showed significantly greater reductions in PTSD symptoms and improvements in ART adherence immediately after the programme and at a three-month follow-up. Increased mindfulness, enhanced resilience, and decreased rumination partially explained the effect on PTSD symptoms. The authors argue the programme offers a low-resource intervention for trauma and treatment adherence in HIV-positive populations.